Eli Lilly and Company (LLY) Investment Research Dashboard
About Eli Lilly and Company (LLY) stock analysis
Get live LLY stock price $1222.61, comprehensive Eli Lilly and Company stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time LLY stock data and investment insights.
Loading chart data...
Eli Lilly and Company (LLY) Overview
Eli Lilly and Company (LLY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, LLY trades at $1222.61 with a market capitalization of 1.15T . Over the past 52 weeks, LLY has traded between $623.78 and $1249.45 , with the current price positioned at approximately 96% of this range . The stock c...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 1.15T
- Current price: $1222.61
- 52-week range: $623.78 - $1249.45
- P/E ratio: 41.56
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This e...
Company Information
- CEO
- David A. Ricks
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 50000
Contact Information
- Website
- https://www.lilly.com
- Address
- Lilly Corporate Center
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 1.2 trillion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 41.6)
✓ Lower volatility stock (Beta: 0.51) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Eli Lilly and Company shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Eli Lilly and Company
- ⚠Investors should consider how Eli Lilly and Company fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 41.6) requires strong growth to justify
Market Cap
1.15T
P/E Ratio (TTM)
41.56
Beta
0.51
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.